Nutrigenomics Market Size to Reach USD 1,289.7 Million in 2028 Growing at a CAGR of 16.2%, according to Emergen Research
Emergen Research has published its latest report titled “Nutrigenomics Market By Application (Cardiovascular Diseases, Cancer Research, Obesity, Diabetes), By Product (Reagents and Kits, Services), and By Region Forecast to 2028”
According to Emergen Research, the global nutrigenomics market size was USD 389.4 Million in 2020 and is expected to reach USD 1,289.7 Million in 2028 and register a revenue CAGR of 16.2% during the forecast period, 2021-2028.
Nutrigenomics is the study and branch of genetic science concerned with how diets affect our genes and, in turn, how genetic differences affect our reactions to nutrients in foods. Nutrigenomics testing aids in the identification and evaluation of certain genetic markers, and accordingly develop a full report with suggestions to assist a person in accomplishing their desired fitness level. The testing helps in identifying sites of metabolic weakness and prevent diet-associated diseases on humans. Increasing awareness regarding the benefits of nutrigenomics testing is a major factor expected to boost market revenue growth over the forecast period. In addition, growing trends of health and fitness among individuals, rising importance of nutritious food to minimize risk of chronic diseases such as diabetes and heart diseases, growing popularity of personalized nutrition among sports enthusiasts and athletes are other factors drive revenue growth of the market over the forecast period.
However, high cost of nutrigenomics testing, lack of skilled physicians, concerns regarding confidentiality of individual’s genetic information are factors that can restrain market revenue growth to a certain extent during the forecast period.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/787
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Obesity Segment Revenue to Expand at a Rapid CAGR:
Obesity segment is expected to register a rapid revenue CAGR over the forecast period attributed to increasing prevalence of obesity due to sedentary lifestyle, and growing popularity of street food. According to World Health Organization (WHO), obesity has become a global epidemic, with at least 2.8 million people dying each year as a result of being overweight or obese. Obesity is now common in low- and middle-income countries, having previously been linked with high-income ones.
Reagents And Kits Segment to Register Significant Revenue Growth:
Reagents and kits segment is expected to register significant revenue growth over the forecast period. The growing popularity of personalized nutrition concept among consumers is expected to surge demand for nutrigenomic testing kits which offer personalized diet based on user’s phenotypic, genetic and medical information. These testing kits helps users to prepare a proper dietary plan, minimizes risk of certain health conditions and improve health.
North America to Account for Largest Revenue Share:
North America is expected to account for largest revenue share in the global market over the forecast period due to increasing adoption of personal genomics, rising prevalence of lifestyle-related disorders such as obesity and diabetes and ongoing research activities on nutrigenomics techniques. Further, presence of key players and growing demand for nutritious food due to its health benefits are some factors expected to contribute to market growth in the region.
Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/787
Major Companies in the Market Include:
- Koninklijke DSM N.V.
- BASF SE
- Danone S.A.
- Unilever plc
- Genova Diagnostics
- Nutrigenomix Inc.
- Metagenics, Inc.
- GX Sciences Inc.
- Xcode Life
Application Outlook (Revenue, USD Million; 2018–2028)
Regional Outlook (Revenue, USD Million; 2018–2028)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of MEA
Antibody-Drug Conjugates (ADC) Market size is expected to reach USD 20.01 Billion in 2028 and register a CAGR of 25.8% during the forecast period. Increasing prevalence of cancer and rapidly increasing geriatric population are some of the key factors driving global antibody-drug conjugates market revenue growth.
Nanorobotics market size is expected to reach USD 14.03 Billion in 2028 and register a CAGR of 10.9% during the forecast period. Steady global nanorobotics market revenue growth can be attributed to various innovations in nanorobotics technology and its rising application in treatment of neurological, cardiovascular, oncological, infectious, and orthopedic diseases, and others.
Implantable cardioverter defibrillator market size is expected to reach USD 8.81 Billion in 2028 and register a CAGR of 2.7% during the forecast period. Global implantable cardioverter defibrillator market revenue growth is driven by increasing prevalence of cardiovascular diseases and rising associated conditions and diseases and risks arising from obesity and sedentary lifestyle.
Single use/disposable endoscopy market size reached USD 1.35 Billion in 2020 and is expected to reach USD 6.29 Billion in 2028 and register a CAGR of 21.1% during the forecast period. A major factor driving market revenue growth is increasing prevalence of chronic and infectious diseases and lifestyle-related health conditions, and digestive system diseases among an increasing patient pool of varying age groups.
Oncolytic virus therapies market size is expected to reach USD 609.7 Million in 2028 and register a CAGR of 26.2% during the forecast period. Rise in prevalence of cancer, increase in number of clinical trials and investment in research & development for cancer therapies are driving the growth of oncolytic virus therapies market.
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-nutrigenomics-market